MedTrace Logo

Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

NCT06058429 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 233

Last updated 2023-10-26

No results posted yet for this study

Summary

This study was conducted on the basis of "Safety Observation of Sabin Strain Inactivated Polio Vaccine (Vero Cell) on primary Immunization, Booster Immunization and Simultaneous Vaccination with Other Vaccines in Infants and Young Children(ID: PRO-sIPV-MA4001-JX). Blood samples were collected in about 200 qualified subjects 1-9 months after their last vaccination of sIPV. And immunogenicity of sIPV and other vaccines simultaneously administrated will be tested, the antibodies against enterovirus (including EV71、CA16、CA6 and CA10) will also be tested.

Conditions

Interventions

OTHER

no intervention

This is an observation study after vaccination, no intervention will be used

Sponsors & Collaborators

  • Jiangxi Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Sinovac Biotech Co., Ltd

    lead INDUSTRY

Eligibility

Min Age
2 Months
Max Age
27 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-16
Primary Completion
2023-09-07
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06058429 on ClinicalTrials.gov